Febrile Neutropenia: Past, Present and Future
A major advance over the last 40 years has been the improved outcome from common malignancies. This has been due, in part, to the availability and improved usage of effective cytotoxic chemotherapy and supportive care. However in some conditions, such as acute leukemia, the use of empirical antimicrobial therapy has been equally important. This chapter will briefly outline some of the important advances in the management of febrile neutropenia over the last 40 years.
KeywordsFebrile Neutropenia Empirical Antimicrobial Therapy Severe Oral Mucositis Febrile Neutropenic Episode Sequential High Dose Chemotherapy
Unable to display preview. Download preview PDF.
- Schimpff, S., Gaya, H., Klastersky, J., Tattersall, M.H., and Zinner, S.H. (1978). Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J. Infect. Dis. 137, 14–29.PubMedCrossRefGoogle Scholar